NasdaqCM - Nasdaq Real Time Price • USD
OpGen, Inc. (OPGN)
As of 12:10 PM EDT. Market Open.
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.13 | -0.09 | -10.37 | -0.29 |
| Low Estimate | -0.13 | -0.09 | -10.37 | -0.29 |
| High Estimate | -0.13 | -0.09 | -10.37 | -0.29 |
| Year Ago EPS | -6 | -3.87 | -15.27 | -10.37 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 640k | 600k | 2.61M | 2.6M |
| Low Estimate | 640k | 600k | 2.61M | 2.6M |
| High Estimate | 640k | 600k | 2.61M | 2.6M |
| Year Ago Sales | 722k | -- | 2.61M | 2.61M |
| Sales Growth (year/est) | -11.40% | -- | 0.10% | -0.40% |
Earnings History
| CURRENCY IN USD | 9/30/2022 | 12/31/2022 | 6/30/2023 | 9/30/2023 |
|---|---|---|---|---|
| EPS Est. | -2.4 | -2 | -0.71 | -0.43 |
| EPS Actual | -6 | -3.87 | -0.93 | -0.46 |
| Difference | -3.6 | -1.87 | -0.22 | -0.03 |
| Surprise % | -150.00% | -93.50% | -31.00% | -7.00% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Current Estimate | -0.13 | -0.09 | -10.37 | -0.29 |
| 7 Days Ago | -0.13 | -0.09 | -10.37 | -0.29 |
| 30 Days Ago | -0.13 | -0.09 | -10.37 | -0.29 |
| 60 Days Ago | -0.13 | -0.09 | -6.19 | -0.29 |
| 90 Days Ago | -0.13 | -0.09 | -2.71 | -1.19 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2023) | Next Qtr. (Mar 2024) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | OPGN | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 97.80% | -- | -- | 1.50% |
| Next Qtr. | 97.70% | -- | -- | 12.10% |
| Current Year | 32.10% | -- | -- | 4.40% |
| Next Year | 97.20% | -- | -- | 13.20% |
| Next 5 Years (per annum) | -- | -- | -- | 10.97% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Downgrade | HC Wainwright & Co.: Buy to Neutral | 8/14/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 7/20/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/26/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/21/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/16/2023 |
Related Tickers
SINT Sintx Technologies, Inc.
0.0389
+6.28%
NAOV NanoVibronix, Inc.
0.7520
-2.04%
BIOL BIOLASE, Inc.
0.1428
-3.51%
HSCS Heart Test Laboratories, Inc.
0.0965
-3.39%
INBS Intelligent Bio Solutions Inc.
2.6700
+7.23%
NUWE Nuwellis, Inc.
0.1675
-42.06%
TIVC Tivic Health Systems, Inc.
1.0399
-3.71%
VVOS Vivos Therapeutics, Inc.
2.5306
+1.84%
AIMD Ainos, Inc.
1.0499
-0.01%
BSGM BioSig Technologies, Inc.
1.3400
+3.08%